Berriot-Varoqueaux N, Dannoura A, Moreau A, Verthier N, Sassolas A, Cadiot G, Lachaux A, Munck A, Schmitz J, Aggerbeck L, Samson-Bouma M
Read the full blog for essential tips on medication safety
Wegovy clinical studies and reported hair loss percentages Wegovy clinical trials show more notable results: Hair loss affected 3% of adult participants compared to 1% in the placebo group [7] The numbers were higher in children 12 and older, where 4% reported hair loss while the placebo group showed no cases [8] Comparing hair loss rates across different GLP-1 medications GLP-1 medications of all types show distinct patterns: Tirzepatide (Mounjaro): Users reported hair loss rates between 4.9% to 5.7% at doses from 5mg to 15mg [8] Zepbound: The overall rates reached 4% to 5%, with women showing much higher numbers 7.1% compared to just 0.5% in men [8] Research from the University of British Columbia shows that people who use semaglutide have a 52% higher chance of hair loss compared to those taking older weight loss medications [9]
Fudim M, White J, Pagidipati NJ, Lokhnygina Y, Wainstein J, Murin J, et al
Hemodynamically, both systemic and pulmonary circulations are in series and the patients are usually asymptomatic unless there are other associated defects
Harvey, Denise R